Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations - PubMed (original) (raw)

Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations

Hao Deng et al. Arch Neurol. 2006 Feb.

Abstract

Background: Mutations in the parkin gene (PRKN) cause autosomal recessive early-onset Parkinson disease (EOPD).

Objective: To investigate the presence of mutations in the PRKN gene in a white family with EOPD and the genotype-phenotype correlations.

Design: Twenty members belonging to 3 generations of the EOPD family with 4 affected subjects underwent genetic analysis. Direct genomic DNA sequencing, semiquantitative polymerase chain reaction, real-time quantitative polymerase chain reaction, and reverse-transcriptase polymerase chain reaction analyses were performed to identify the PRKN mutation.

Results: Compound heterozygous mutations (T240M and EX 5_6 del) in the PRKN gene were identified in 4 patients with early onset (at ages 30-38 years). Although heterozygous T240M and homozygous EX 5_6 del mutations in the PRKN gene have been previously described, this is, to our knowledge, the first report of these mutations in compound heterozygotes. The phenotype of patients was that of classic autosomal recessive EOPD characterized by beneficial response to levodopa, relatively slow progression, and motor complications. All heterozygous mutation carriers (T240M or EX 5_6 del) and a 56-year-old woman who was a compound heterozygous mutation carrier (T240M and EX 5_6 del) were free of any neurological symptoms.

Conclusions: Compound heterozygous mutations (T240M and EX 5_6 del) in the PRKN gene were found to cause autosomal recessive EOPD in 4 members of a large white family. One additional member with the same mutation, who is more than 10 years older than the mean age at onset of the 4 affected individuals, had no clinical manifestation of the disease. This incomplete penetrance has implications for genetic counseling, and it suggests that complex gene-environment interactions may play a role in the pathogenesis of PRKN EOPD.

PubMed Disclaimer

Cited by

Identification of a Novel Mutation in the ABCA4 Gene in a Chinese Family with Retinitis Pigmentosa Using Exome Sequencing.
Huang X, Yuan L, Xu H, Zheng W, Cao Y, Yi J, Guo Y, Yang Z, Li Y, Deng H. Huang X, et al. Biosci Rep. 2018 Apr 27;38(2):BSR20171300. doi: 10.1042/BSR20171300. Biosci Rep. 2018. PMID: 29437900 Free PMC article.
Twenty years since the discovery of the parkin gene.
Hattori N, Mizuno Y. Hattori N, et al. J Neural Transm (Vienna). 2017 Sep;124(9):1037-1054. doi: 10.1007/s00702-017-1742-7. Epub 2017 Jun 15. J Neural Transm (Vienna). 2017. PMID: 28620835 Review.
PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.
Aboud AA, Tidball AM, Kumar KK, Neely MD, Han B, Ess KC, Hong CC, Erikson KM, Hedera P, Bowman AB. Aboud AA, et al. Neurobiol Dis. 2015 Jan;73:204-12. doi: 10.1016/j.nbd.2014.10.002. Epub 2014 Oct 12. Neurobiol Dis. 2015. PMID: 25315681 Free PMC article.
The Role of Sex and Sex Hormones in Neurodegenerative Diseases.
Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, Cristofani R, Galbiati M, Maggi A, Poletti A. Vegeto E, et al. Endocr Rev. 2020 Apr 1;41(2):273-319. doi: 10.1210/endrev/bnz005. Endocr Rev. 2020. PMID: 31544208 Free PMC article. Review.
Genetic Paradoxes in an Italian Family with PARK2 Multiexon Duplication.
Petrucci S, Ferrazzano G, Ginevrino M, Tolve M, Berardelli I, Berardelli A, Fabbrini G, Valente EM. Petrucci S, et al. Mov Disord Clin Pract. 2017 Sep 8;4(6):889-892. doi: 10.1002/mdc3.12531. eCollection 2017 Nov-Dec. Mov Disord Clin Pract. 2017. PMID: 30713982 Free PMC article. No abstract available.

Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations - PubMed (original) (raw)